FDA Approves Cephalon’s CLL Therapy Treanda With Broad Label

A broad label for Cephalon's Treanda could increase the sales potential for the chronic lymphocytic leukemia therapy, which can be used across multiple lines of treatment and as monotherapy or in combination regimens